Results 51 to 60 of about 3,066,996 (254)

A Polyamine-Based Dinitro-Naphthalimide Conjugate as Substrates for Polyamine Transporters Preferentially Accumulates in Cancer Cells and Minimizes Side Effects in vitro and in vivo

open access: yesFrontiers in Chemistry, 2020
Naphthalimides, such as amonafide and mitonafide in clinical trials, have been developed as antitumor agents for orthotopic tumor. However, the serious side effects in cancer patients limit their applications.
Jing Ma   +18 more
doaj   +1 more source

Advances in Cryochemistry: Mechanisms, Reactions and Applications

open access: yesMolecules, 2021
It is counterintuitive that chemical reactions can be accelerated by freezing, but this amazing phenomenon was discovered as early as the 1960s. In frozen systems, the increase in reaction rate is caused by various mechanisms and the freeze concentration
Lu-Yan An, Zhen Dai, Bin Di, Li-Li Xu
doaj   +1 more source

Distribution in Rat Blood and Brain of TDMQ20, a Copper Chelator Designed as a Drug-Candidate for Alzheimer’s Disease [PDF]

open access: gold, 2022
Lan Huang   +7 more
openalex   +1 more source

Characteristics of drug users who do or do not have care of their children

open access: yes, 2004
Aims - To compare the relative frequency of eight indicators of problem drug use and potentially adverse social circumstances in drug using parents and non-parents and to explore whether a profile based on these characteristics differs according to ...
Advisory Council on the Misuse of Drugs   +18 more
core   +1 more source

Deep representation learning of chemical-induced transcriptional profile for phenotype-based drug discovery

open access: yesNature Communications
Artificial intelligence transforms drug discovery, with phenotype-based approaches emerging as a promising alternative to target-based methods, overcoming limitations like lack of well-defined targets.
Xiaochu Tong   +11 more
doaj   +1 more source

Targeting dual-specificity tyrosine phosphorylation-regulated kinase 2 with a highly selective inhibitor for the treatment of prostate cancer

open access: yesNature Communications, 2022
The kinase DYRK2 is a known oncogene but its role in prostate cancer is unexplored. Here, the authors identify DYRK2 as a target for prostate cancer with a role in invasion and they discover a specific DYRK2 inhibitor that has good pharmacokinetics and ...
Kai Yuan   +17 more
doaj   +1 more source

RETRACTED: Identify Biomarkers and Design Effective Multi-Target Drugs in Ovarian Cancer: Hit Network-Target Sets Model Optimizing [PDF]

open access: gold, 2022
Amir Abbas Esmaeilzadeh   +7 more
openalex   +1 more source

Design, Synthesis and Anticancer Activity of a New Series of N-aryl-N′-[4-(pyridin-2-ylmethoxy)benzyl]urea Derivatives

open access: yesMolecules, 2021
The development of cancer treatments requires continuous exploration and improvement, in which the discovery of new drugs for the treatment of cancer is still an important pathway.
Shicheng Hou   +9 more
doaj   +1 more source

Teaching of Critical Analysis of Drug Advertisements to Medical Students [PDF]

open access: yes, 2011
Background: Medical practitioners utilize drug promotional materials from pharmaceutical companies as a major source of information especially in developing countries.
Adiga, S, Bairy, KL, Chogtu, B, Nayak, V
core   +1 more source

Thermochemical, spectral and biological activity prediction of some methylpyridine derivatives: a computational approach

open access: yesDiscover Chemistry
Pyridine and its derivatives play a vital role in pharmaceutical and pesticide applications. However, prolonged exposure to pyridine can lead to significant health risks due to its ability to enter the body via inhalation and absorption.
Md. Arifur Rahman   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy